ORYZON announces First Patient In in NET, a collaborative Phase II basket study with iadad... 18/01/2023 Healthcare Access to innovation Corporate Trial will assess the safety and efficacy of iadademstat in pulmonary and extrapulmonary NECs Partners - Oryzon Genomics
Nimble Diagnostics cierra una ronda de financiación de un millón de euros 18/01/2023 Corporate NIMBLE Diagnostics, ha cerrado con éxito una ronda de financiación donde han conseguido más un millón de euros liderada... Partners - Germans Trias i Pujol Research Institute (IGTP)
Gate2Brain receives €2.5M funding from the european innovation council to develop a new te... 12/01/2023 Healthcare Access to innovation Corporate The spin-off of IRB Barcelona, the UB and SJD has a patented technology based on peptides (small proteins) that... Partners - Gate2Brain
Technological support in bioprocesses market uptake 12/01/2023 Access to innovation Corporate One of the key challenges in the process of developing new bioproducts is to overcome the transition period in which a... Partners - CENER
BCN HEALTH publishes a study assessing the incidence and medical costs of female breast ca... 12/01/2023 Access to innovation Corporate BCN HEALTH ha publicado el estudio Hospital Incidence and Medical Costs of Female Breast Cancer in Spain: A... Partners - BCN Health
Merck, the science and technology company, rewards CEU students' research 12/01/2023 Healthcare Access to innovation Corporate The science and technology company Merck has awarded the Merck Chair Award to the best works of the Master's Degree in... Partners - Merck
Almirall relies on collaboration to accelerate its R&D process 12/01/2023 Healthcare Access to innovation Corporate R&D is at the heart of Almirall's strategy Partners - Almirall
PharmaMar leads the TERINMUN initiative, a research consortium in search of immunotherapie... 22/12/2022 Healthcare Access to innovation Innovative drugs Financing Corporate The project has been approved in the call for public-private collaboration projects of the Ministry of Science and... Partners
3P Biopharmaceuticals among the 500 fastest growing companies in Spain 20/12/2022 Corporate This is the first year that the company appears in the ranking established by CEPYME Partners - 3PBIOVIAN
ORYZON awarded EU grant to further explore the role of iadademstat in oncological immunoth... 16/12/2022 Healthcare Access to innovation Corporate Project will assess the efficacy of iadademstat in combination with checkpoint inhibitors and/or oncological vaccines Partners - Oryzon Genomics
